Press release
Rising Incidence of Cancer Cases to Propel the Growth in the Market for Intratumoral Cancer Therapies: FMI Study
Intratumoral Cancer Therapies Market
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16153
The growth is attributed to the increasing prevalence of cancer cases, pushing the regulatory bodies to work on the research and development. For instance, in September 2022, the Hadassah Cancer Research Institute (HCRI), Jerusalem declared that it will lead the CancerRNA, a global forum working towards development and application of RNA-based immunotherapy to effectively utilize anti-cancer immune responses.
In terms of market share and revenue, the North American market is predicted to be the most lucrative market during the forecast period with a revenue share of 40%. The region's growth is driven by the presence of various biotechnology and medical device firms. For instance, in March 2020, Johnson and Johnson received the US FDA Breakthrough Therapy Designation for JNJ-61186372 (JNJ-6372) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).
View Full Report@ https://www.futuremarketinsights.com/reports/intratumoral-cancer-therapies-market
Key Takeaways from the Market Study
From 2017-2022, the Intratumoral Cancer Therapies market grew at CAGR of 7%.
The global Intratumoral Cancer Therapies market is expected to grow with a 10% CAGR during 2023-2033.
As of 2033, the Intratumoral Cancer Therapies market is expected to reach US$ 552.36 Billion.
Checkpoint inhibitors segment is poised to register the highest growth rate through 2033.
North America is expected to possess 40% market share for Intratumoral Cancer Therapies market in North America.
The European market is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.
By application, lung cancer is estimated to account for the largest share of the market.
"Cancer is among the top causes of mortality worldwide, and its incidence is increasing at an alarming rate. As a result, healthcare experts are concentrating on the development of efficient treatment and diagnosis solutions in order to reduce the incidence level." says an FMI analyst
Market Competition
Key players in the Intratumoral Cancer Therapies market are Amgen Inc, AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, Pfizer Inc, Novarts AG, Johnson & Johnson, and Eli Lily Company, F.
Gland Pharma has launched the cancer treatment medicine Bortezomib for Injection in the United States in 2022. The drug business stated in a statement that it has released the medicine in the US market through a partner who has acquired permission from the US Food and Drug Administration (USFDA). The business claims that its medicine is medically similar to Velcade for Injection from Takeda Pharmaceuticals. Bortezomib for Intravenous is used to treat cancers such as myeloma and mantle cell lymphoma.
Ask An Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-16153
More Insights Available
FMI, in its new offering, presents an unbiased analysis of the global Intratumoral Cancer Therapies market, presenting historical analysis from 2017 to 2022 and forecast statistics for the period of 2023-2033.
The study reveals essential insights on the basis of technology (Monoclonal Antibodies, Vaccines, Checkpoint Inhibitors, Cell Therapies, Immune System Modulators, Adoptive Cell Transfer, Cytokines), application (Lung Cancer, Breast Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Others), end-users (Hospitals, Cancer Research Centres, Clinics) & region.
About the Healthcare Domain at Future Market Insights
The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-16153
Key Segments Profiled in the Intratumoral Cancer Therapies Industry Survey
Technology:
• Monoclonal Antibodies
• Vaccines
• Checkpoint Inhibitors
• Cell Therapies
• Immune System Modulators
• Adoptive Cell Transfer
• Cytokines
Application:
• Lung Cancer
• Breast Cancer
• Melanoma
• Prostate Cancer
• Head & Neck Cancer
• Others
End-users:
• Hospitals
• Cancer Research Centres
• Clinics
Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
About FMI:
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising Incidence of Cancer Cases to Propel the Growth in the Market for Intratumoral Cancer Therapies: FMI Study here
News-ID: 2863808 • Views: …
More Releases from futuremarketinsights
Airway Management Devices Market
The airway management devices market is anticipated to be valued at US$ 1.6 billion in 2023, with total revenue recording a 3.6% CAGR from 2023 to 2033, reaching US$ 2.2 billion.
The airway management devices market was valued at US$ 1.5 billion in 2022, with a 3.2% CAGR expected throughout the projected period. The global market's absolute dollar growth is US$ 668.5 million.
Request Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-7775
The rising frequency of respiratory disorders…
Large Molecule Bioanalytical Testing Services Market size worth US$ 4.7 Billion …
The Large Molecule Bioanalytical Testing Services Market revenues were estimated at US$ 1.5 Billion in 2023 and is anticipated to grow at a CAGR of 12.1% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 4.7 Billion.
The rising use of bioanalytical testing in clinical trials of biomarkers, big compounds, and others is a major factor…
Blood Pressure Transducers Market to expand at a CAGR of 6.22% by 2022 to 2032 | …
According to the latest report by Future Market Insights on global Blood Pressure Transducers market, the market is expected to register the growth of 6.22% CAGR through 2022 - 2032.
The blood pressure transducers market valued at USD 903.14 million as of 2022 and is anticipated to increase by 6.22 percent annually to reach USD 1651.26 million by 2032.
View Full Report@ https://www.futuremarketinsights.com/reports/blood-pressure-transducers-market
With the latest insights and statistics from the biggest pharmaceutical and healthcare…
Synthetic Biology Market will reach a value of US$ 138.8 Billion by 2032 | FMI
The global synthetic biology market is expected to be worth US$ 15.8 billion by the end of 2022, and to grow at a CAGR of 24.3% to be worth US$ 138.8 billion by 2032. According to a recent study by Future Market Insights, the oligonucleotides segment by product will lead the market with a share of approximately 43.6% in 2021.
View Full Report@ https://www.futuremarketinsights.com/reports/synthetic-biology-market
The synthetic biology market is a technology that is currently…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
